Home / Generics

Generics

News

COVID-19 drugs: Gilead’s remdesivir and Algernon’s alternative posted 22/05/2020

Gilead Sciences has signed licensing agreements with five generics manufacturers based in India and Pakistan to increase prod...

FDA approves Proventil and Daraprim generics posted 12/05/2020

The US Food and Drug Administration (FDA) has approved the first generic version of a commonly used inhaler, marketed as Prov...

FDA approves lung cancer and anticoagulant generics posted 20/03/2020

The US Food and Drug Administration (FDA) has issued a final approval for a generic version of Alimta (pemetrexed) and two ne...

Chinese company makes copy of patented coronavirus treatment remdesivir posted 03/03/2020

China’s BrightGene has successfully produced remdesivir, an experimental treatment for coronavirus, however, patents for the...

EMA recommends four new generics posted 21/02/2020

At the Committee for Medicinal Products for Human Use’s (CHMP) January 2020 meeting, the Committee recommended four new gener...

 

Research

US policy to combat high-priced generics posted 29/05/2020

The cost of prescription drugs is a concern in the US. Drug prices typically decline once a generic drug is approved due to m...

Why does the US face high-priced generics and drug shortages? posted 22/05/2020

Healthcare budgets in the US are under strain and the cost of prescription drugs is a continuous concern. Generic drugs offer...

Comparison of economic loss between generics and patented drugs in Indonesia posted 17/04/2020

Poor management of the drug inventory in hospitals can be caused by stagnant and stock-out conditions, which might lead to ec...

Generics outreach programmes should target high income groups posted 30/03/2020

Patients with lower incomes are more likely to use generic drugs, finds a literature review from Auburn University, Alabama,...

Pharmacopeial standards may increase generics competition posted 13/03/2020

Pharmacopeias, which contain descriptions of drug preparations, are critical for ensuring the safety of drug products. A stud...

 

General

CMS proposes new measures to rate generic usage posted 07/05/2020

The Centers for Medicare & Medicaid Services (CMS) is actively working to promote competition and lower costs for drugs,...

Science, outreach, development: US Generics Drugs Office reaches new highs in 2019 posted 24/04/2020

The US Food and Drug Administration (FDA) Office of Generic Drugs 2019 Annual report gave updates on the number of generics a...

Improving the pathway for generics approval in the US: 2019 update posted 24/04/2020

The US Food and Drug Administration’s (FDA) Office of Generic Drugs released their 2019 annual report in February 2020. This...

Generics approvals remain high in US in 2019 posted 24/04/2020

In February 2020, the US Food and Drug Administration’s (FDA) Office of Generic Drugs released their 2019 Annual report which...

US lawmakers question FDA on complex generics approvals posted 28/02/2020

A US Congress Committee have sent a letter to the US Food and Drug Administration (FDA) regarding concerns over the approval...